Literature DB >> 9517890

Prevalence of enterotropic and polytropic mouse hepatitis virus in enzootically infected mouse colonies.

F R Homberger1, L Zhang, S W Barthold.   

Abstract

Mouse hepatitis virus (MHV) causes the most prevalent viral infection in contemporary laboratory mouse colonies. According to their primary replication site, different strains of MHV segregate into two overlapping biotypes, enterotropic and polytropic. These two groups vary greatly in disease pattern, pathogenicity, immune response, and duration of infection. Historically, the polytropic MHV strains represent the extensively studied prototype strains that have minimal enterotropism, whereas enterotropic MHV strains have been less characterized. Anecdotal reports suggest that most MHV strains encountered today belong to the enterotropic biotype. We have identified 15 isolates of MHV from 19 independent enzootically infected mouse colonies. Sequencing of a variable region of the nucleoprotein (N) gene of each isolate confirmed that all were independent genetic variants. The principal tissue tropism of the new isolates was determined by experimental inoculation of infant mice and examination of intestine, liver, spleen, and brain for lesions. Nine isolates infected only intestine; four isolates infected intestine and liver; one isolate infected intestine, liver, and brain; and one isolate infected liver. These results confirm that the enterotropic MHV biotype is predominant in contemporary laboratory mouse colonies. The MHV biotype features need to be taken into consideration when dealing with MHV infections.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9517890

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  19 in total

1.  MHC-genotype of progeny influenced by parental infection.

Authors:  T Rülicke; M Chapuisat; F R Homberger; E Macas; C Wedekind
Journal:  Proc Biol Sci       Date:  1998-04-22       Impact factor: 5.349

2.  Murine Coronavirus Cell Type Dependent Interaction with the Type I Interferon Response.

Authors:  Kristine M Rose; Susan R Weiss
Journal:  Viruses       Date:  2009-12-01       Impact factor: 5.048

3.  Targeted disruption of the Ceacam1 (MHVR) gene leads to reduced susceptibility of mice to mouse hepatitis virus infection.

Authors:  D M Blau; C Turbide; M Tremblay; M Olson; S Létourneau; E Michaliszyn; S Jothy; K V Holmes; N Beauchemin
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

Review 4.  Coronavirus pathogenesis.

Authors:  Susan R Weiss; Julian L Leibowitz
Journal:  Adv Virus Res       Date:  2011       Impact factor: 9.937

5.  Biochemical and genetic analyses of murine hepatitis virus Nsp15 endoribonuclease.

Authors:  Hyojeung Kang; Kanchan Bhardwaj; Yi Li; Satheesh Palaninathan; James Sacchettini; Linda Guarino; Julian L Leibowitz; C Cheng Kao
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

6.  Using reduced personal protective equipment in an endemically infected mouse colony.

Authors:  Samuel W Baker; Kevin A Prestia; Brian Karolewski
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-05       Impact factor: 1.232

7.  C1qa deficiency in mice increases susceptibility to mouse hepatitis virus A59 infection.

Authors:  Han Woong Kim; Sun Min Seo; Jun Young Kim; Jae Hoon Lee; Han Woong Lee; Yang Kyu Choi
Journal:  J Vet Sci       Date:  2021-05       Impact factor: 1.672

Review 8.  Pathogenesis of murine coronavirus in the central nervous system.

Authors:  Susan J Bender; Susan R Weiss
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-06       Impact factor: 4.147

Review 9.  Multiple sclerosis: experimental models and reality.

Authors:  Hans Lassmann; Monika Bradl
Journal:  Acta Neuropathol       Date:  2016-10-20       Impact factor: 17.088

10.  Suppression subtractive hybridization method for the identification of a new strain of murine hepatitis virus from xenografted SCID mice.

Authors:  Mohammed M Islam; Brendan Toohey; Damian F J Purcell; George Kannourakis
Journal:  Arch Virol       Date:  2015-09-08       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.